| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/21/2008 | US20080199899 Method For Screening Modulators of Mitochondrial Functioning and New Modulators Obtained |
| 08/21/2008 | US20080199898 Folded peptide backbone each end of which is conjugated to a fluorophore, which when cleaved as by digestion with a protease, the fluorophores provide high intensity signals; histology |
| 08/21/2008 | US20080199532 Congestive heart failure; induce vasodilation |
| 08/21/2008 | US20080199481 B cell-attracting chemokine 1 specific immunoglobulin for use in treatment and prevention of rheumatoid arthritis |
| 08/21/2008 | US20080199476 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199436 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 08/21/2008 | CA2678432A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | CA2678013A1 Lung cancer-targeted peptides and applications thereof |
| 08/21/2008 | CA2677894A1 Control of transport properties to and from nanoparticle surfaces |
| 08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
| 08/20/2008 | EP1958961A2 Transport Vectors |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1957522A2 AVß6 PEPTIDE LIGANDS AND THEIR USES |
| 08/20/2008 | EP1957518A1 New cyclic peptide compounds |
| 08/20/2008 | EP1957517A2 Use of peptides that bind to tpo receptor |
| 08/20/2008 | EP1957096A2 Cyclic peptide isolation by spray drying |
| 08/20/2008 | EP1957094A2 Calcium binding peptides |
| 08/20/2008 | EP1470153B1 Two gonadotropin releasing hormones and a method to isolate the same |
| 08/20/2008 | EP1368050B1 Virus derived antimicrobial peptides |
| 08/20/2008 | EP1227829B1 Novel chimeric analgesic peptides |
| 08/20/2008 | CN101247818A Use of MAS G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 08/20/2008 | CN101245098A Antimicrobial antiphlogistic antagonism polypeptide simulating MD2 |
| 08/20/2008 | CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease |
| 08/20/2008 | CN100412087C Sequence number2 bioactive peptide |
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7414105 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production |
| 08/19/2008 | US7414029 Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
| 08/19/2008 | US7414023 polypeptides/peptidomimetics; solid phase synthesis; for use in diagnositc assays |
| 08/19/2008 | US7413877 Bacterial expression of bowman-birk protease inhibitors and variants thereof |
| 08/19/2008 | US7413742 Clostridial toxin derivatives and methods for treating pain |
| 08/19/2008 | US7413538 Epitopes formed by non-covalent association of conjugates |
| 08/14/2008 | WO2007134384A3 Selective modulation of receptor signalling |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080194490 At4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents |
| 08/14/2008 | US20080194486 Novel Anti-Obesity Agents |
| 08/14/2008 | US20080194484 Truncated Motilin-Like (TML) peptides; use modulating contractility in duodenum or jejunum tissue and pancreatic secretion of hormones and digestive enzymes |
| 08/14/2008 | US20080194482 VPAC2 receptor peptide agonists of given amino acid sequences; PACAP-preferring type 2 (PAC2) receptor; VIP-shared type 2 receptors (VPAC2); induce insulin secretion from the pancreas only in the presence of high blood glucose levels; side effect reduction; diabetes |
| 08/14/2008 | US20080194480 Polypeptide for reducing the growth rate of cancer cells; polypeptide of given sequence that is down-regulated in cancer |
| 08/14/2008 | US20080194470 Nim811 In Cerebral Ischemia and Brain and Spinal Cord Injury |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080194465 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/14/2008 | US20080194464 Chemical intermediate thereto; effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 08/14/2008 | US20080193976 Pseudomonas Exotoxin A Cd4+T-Cell Epitopes |
| 08/14/2008 | US20080193971 Using transferrin digestion as tool to generate meningococcal polypeptide products for use in preparing vaccine to prevent or treat meningitis and/or septic shock |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA) |
| 08/14/2008 | US20080193377 treating solid tumors with drug-polymeric conjugates, that specifically target endothelial cells supporting tumor angiogenesis; tissue-targeted therapy; radiotherapy |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/13/2008 | EP1954717A2 Peptide inhibitors of abl kinases |
| 08/13/2008 | EP1791571B1 Radiofluorinated peptides |
| 08/13/2008 | EP1664093B8 Antitumoral compounds based on Kahalalide F |
| 08/13/2008 | EP1654280B8 Preparation of somatostatin peptides |
| 08/13/2008 | EP1483290B1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 08/13/2008 | EP1359931A4 Prevention of diabetes by administration of gnrh antagonists |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | CN101240032A Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application |
| 08/13/2008 | CN101240018A Peptides and related compounds having thrombopoietic activity |
| 08/13/2008 | CN101240017A A uro-genital disease treatment system |
| 08/13/2008 | CN101240013A High purity lipopeptides, lipopeptide micelles, processes for preparing same |
| 08/13/2008 | CN101239190A Vitamin receptor binding drug delivery conjugates |
| 08/13/2008 | CN101239179A Non-aqueous polar aprotic peptide formulations |
| 08/13/2008 | CN100410276C Polypeptide |
| 08/13/2008 | CN100410272C CYP4A11 polypeptide |
| 08/12/2008 | US7410950 Peptides of CaV2.2 that inhibit pain |
| 08/12/2008 | US7410949 Genetically engineered truncated analogs of significantly lower-molecular-weight and having equal or better potency, pharmacokinetic properties and pharmacological properties as existing Y2R agonists; also pegylated analogs; treating obesity; dietetics; metabolic disorders |
| 08/12/2008 | US7410943 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/12/2008 | CA2135787C Polypeptide bombesin antagonists |
| 08/07/2008 | WO2008095063A1 Stabilized p53 peptides and uses thereof |
| 08/07/2008 | WO2008093982A1 Novel macromolecule transduction domains and methods for identification and uses thereof |
| 08/07/2008 | WO2008093060A2 Peptides and their use |
| 08/07/2008 | WO2008093059A1 Basic peptides and their use as combined antibacterial-antifungine agents |
| 08/07/2008 | WO2008093058A2 Peptides and their use |
| 08/07/2008 | WO2008092281A1 Template-fixed peptidomimetics |
| 08/07/2008 | WO2007111969A3 C-reactive protein apheresis |
| 08/07/2008 | US20080188640 Immunodeficiency recombinant poxvirus |
| 08/07/2008 | US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction |
| 08/07/2008 | US20080188421 Hunter-Killer Peptides and Methods of Use |
| 08/07/2008 | US20080188413 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 08/07/2008 | US20080188004 Assay for diabetes |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187956 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification |
| 08/07/2008 | US20080187904 Hepatitis C viral amino acid sequences comprising ruthenium chelate for use in generation of immunoglobulin for detection and prevention of viral infection; genetic vaccines; immunodiagnostics |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080187490 Administering a purified polypeptide, with high affinity to the CH2-CH3 domain of an immunoglobulin molecule; inhibiting the binding of immune complexes to effector molecules |
| 08/07/2008 | CA2706744A1 Anti-fungal peptides and their use |
| 08/07/2008 | CA2706738A1 Treatment of mixed pathogen infections |
| 08/07/2008 | CA2706621A1 Anti-bacterial peptides and their use |
| 08/07/2008 | CA2677045A1 Stabilized p53 peptides and uses thereof |
| 08/07/2008 | CA2676865A1 Template - fixed peptidomimetics |
| 08/07/2008 | CA2676820A1 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
| 08/07/2008 | CA2676797A1 Novel macromolecule transduction domains and methods for identification and uses thereof |
| 08/06/2008 | EP1953551A2 Prion protein ligands and methods of use |
| 08/06/2008 | EP1953227A1 Lipopolysaccharide- or lipid a-binder, and novel peptide |
| 08/06/2008 | EP1951750A2 Modulation of angiogenesis by a-beta peptide fragments |
| 08/06/2008 | EP1951747A1 Process and intermediates for the synthesis of caspofungin |
| 08/06/2008 | EP1951746A1 Solution-phase synthesis of leuprolide and its intermediates |
| 08/06/2008 | EP1951745A2 Casein-derived antimicrobial peptides and lactobacillus strains that produce them |